The effects of a continuous infusion of the calcium antagonist nimodipine (1 j,Lg kg -1 min -1) on local CBF (LCBF) and local cerebral glucose utilisation (LCGU) were studied, using the quantitative autoradio graphic [14C]iodoantipyrine and [14C]2-deoxyglucose techniques in 34 anatomically discrete regions of the brain in lightly restrained, conscious rats. The infusion of ni modipine at this concentration produced only a small (8%) reduction in the MABP. The administration of ni modipine did not alter the rate of glucose utilisation in any of the regions examined. By contrast, in 24 regions, CBF was increased significantly by 39-84% from control
Nimodipine (a dihydropyridine derivative) is a calcium antagonist with potent actions within the cerebral circulation. Nimodipine effects the dilata tion of cerebral arteries and arterioles in vitro and in situ, and it is generally accepted that the admin istration of this agent elevates CBF (Harper et aI., 1981; Kazda et aI., 1982; Haws et aI., 1983; Mo hamed et aI., 1984) .
In contrast to these detailed studies of the effects of nimodipine on the cerebral vasculature and on cerebral tissue perfusion, there have been no sys tematic investigations of cerebral oxidative metab olism during the administration of calcium antago nists. The level of cerebral oxidative metabolism is a crucial determinant of the level of CBF under normal circumstances (Kusch in sky and Wahl, 1978) . The effects of many pharmacological treat ments on CBF are the indirect consequence of al terations in cerebral metabolism provoked by the levels (for example, cerebral cortices, hippocampus, hy pothalamus, and most thalamic nuclei). In vehicle-treated animals, there was an excellent correlation (p < 0.01) between the local levels of CBF and glucose utilisation, with the ratio of flow to glucose use being � 1. 5 ml j,Lmol-1 in each brain region. During nimodipine treat ment, there was a similarly excellent correlation (p < 0.01) between LCBF and LCGU, but the median ratio between local flow and glucose use increased to 2. 5 ml f,Lmol-1. Key Words: Calcium antagonist-Cerebral blood flow -Deoxyglucose -Iodoantipyrine-N imodi pine.
drug, rather than a direct action of the agent in ce rebral vessels (Edvinsson and MacKenzie, 1977; Kuschinsky and Wahl, 1978) . Although global ce rebral oxygen consumption appears to be minimally altered during nimodipine administration (Harper et ai., 1981; Haws et aI., 1983; Steen et aI., 1983) , the recent demonstrations of highly specific dihydro pyridine binding sites in cerebral tissue (Bellemann et aI., 1982 (Bellemann et aI., , 1983 Ferry and Glossmann, 1982; Qui rion, 1983) and of behavioural alterations in animals after the administration of calcium antagonists (Hoffmeister et ai., 1982; Shah et aI., 1983) indicate that nimodipine may act on cerebral tissue itself in addition to any actions it may exert on cerebral ves sels. In the present study, in an attempt to examine the functional significance of receptors for nimodi pine present within the CNS, we have examined the effects of nimodipine on local cerebral glucose phosphorylation, using the quantitative autoradio graphic [J4C]2-deoxyglucose (2-DG) technique in conscious rats (Sokoloff et aI., 1977) . Furthermore, in a parallel series of investigations, we have as sessed the effects of nimodipine on local CBF (LCBF) using the autoradiographic [l4C]iodo antipyrine technique (Sakurada et aI., 1978) , and co mpared and contrasted these effects with the ac tion of nimodipine on local cerebral glucose utili zation (LeG U).
METHODS

General surgery and animal preparation
The experiments were performed on 23 male Sprague Dawley rats, weighing between 350 and 420 g, which were allowed unrestricted access to food and water until the day of the experiment. The animals were anaesthetised in a Perspex box into which an anaesthetic gas mixture (70% nitrous oxide/30% oxygen, containing 5% halo thane) was delivered. Anaesthesia was then maintained by means of a face mask through which I % halothane was administered. Two small incisions (�1 cm) were made in the groin on each side, and the femoral vessels were exposed. Polythene catheters (15 cm long) filled with heparinised solution (10 V/ml) were introduced ret rogradely into both femoral arteries and veins for the con tinuous measurement of arterial blood pressure, with drawal of arterial blood (for blood gas and plasma glucose measurements and blood sampling), and the administra tion of drugs and radioactive tracer. The cannulas and the wounds were covered by local anaesthetic cream before the wounds were closed by suturing. The wounds were covered with gauze pads, and plaster of Paris bandage (Gypsona; width 7. 5 cm) was placed around the lower abdomen, pelvis, and the upper third of the thighs. The anaesthesia was then discontinued, and at least 3 h elapsed before the experiments were started. Body tem perature was maintained at 37 ± O.SOC by external heating.
Determination of LCBF
LCBF was measured using the quantitative autoradio graphic technique with [l4C]iodoantipyrine as tracer (Sak urada et aI., 1978) . [14C]Iodoantipyrine (50 f.LCi in 1. 5 ml saline) was infused intravenously over a 30-s period on a "ramp" schedule; i.e., the rate of infusion was increased progressively so that arterial tracer concentration would be highest at the end of the experiments. During admin istration of the tracer, 15-18 timed samples of arterial blood were collected in preweighed filter paper discs from a free-flowing femoral arterial catheter. At the end of the infusion of the isotope, the animals were killed by decap itation, and the brains were quickly dissected out and frozen in isopentane at -45°C within 2-3 min. The filter discs were tightly capped in scintillation vials to prevent evaporation, and reweighed. Hydrogen peroxide (30% wt/vol, 0.4 ml) and water (1 m\) were added to bleach the blood and extract the radioisotope; 10 ml of liquid scin tillant (Pico-fluor) was added. Tw enty-four hours was al lo wed to elapse before liquid scintillation analysis. Quench correction was performed by the external sample channels ratio method by reference to commercially available, differentially quenched standards (Koch Light, Buckinghamshire, England). In addition, in each animal, the accuracy of this quench correction was checked in two vials by adding a known amount of internal standard ([14C]toluene) and determining the resultant increment in disintegrations per minute.
Brain sections (20 f.Lm thick) were cut in a cryostat at -22°C, and 3 in every 20 sections were mounted on glass cover slips and dried on a hot plate. Autoradiograms were prepared from these sections together with a set of nine precalibrated epoxy resin standards (concentration range 44-1175 nCi/g) by applying them to X-ray film (Kodak SB-5) for 7 -10 days in light-tight cassettes.
Determination of LCGU
LCGU was measured using the [l4C]2-DG technique (Sokoloff et aI., 1977) . The isotope (50 f.LCi per animal), dissolved in saline, was given at a constant rate over 30 s. A total of 14 timed samples of arterial blood were with drawn from the femoral cannulas and collected into hep arinised plastic centrifuge tubes over the subsequent 45 min according to a predetermined time schedule. The volume of the arterial samples was �75 f.L1 of whole blood; this same volume was replaced by saline solution. The arterial blood plasma was separated from the blood sample content by centrifugation within a few minutes of withdrawal. Twenty microlitres of each plasma sample was pipetted from the centrifuge tubes into 1 ml of dis tilled water in 14 plastic scintillation vials. The glucose level was determined on a lO-f.Ll aliquot of plasma, using a semiautomated glucose analyser (Beckman) with a glu cose oxidase method. At the end of 45 min, the rats were killed by decapitation and the brains processed for quan titative autoradiography in the same manner as for the measurement of LCBF.
Densitometric analysis of autoradiograms
Analysis of the resultant images on the X-ray film was performed using a computer-based densitometer with epi diascope and video display (Quanti met, Cambridge In struments, England), with reference to the precalibrated standards. For each region, in both series of experiments, bilateral determination of optical density was made on 6 different autoradiographic images that contained the re gion, and the mean optical density of these 12 measure ments was used to calculate 14C tissue concentrations. The area of measurement varied from 0. 25 mm2 for large homogeneous regions of the CNS, such as hypothalamus and caudate nucleus, to 0.02 mm2 for smaller brain areas, such as substantia nigra (pars compacta) and hippo campus molecular layer. The size of the frame was main tained constant for the same region in different animals. The neuroanatomical criteria used to locate the regions and densitometric procedures were identical in investi gations of both blood flow and glucose utilization.
Calculation and statistical analysis LCBF was calculated from the time course of [14CJiodoantipyrine in arterial blood and the 14C concen tration in cerebral tissue, using the equation described by Sakurada et al. (1978) . The cerebral tissue blood partition coefficient employed for iodoantipyrine was 0. 8 (Saku rada et aI., 1978) . LCGU was calculated using the opera tional equation of Sokoloff et al. (1977) . The rate con stants and "lumped" constant used in the computation of the glucose utilisation were those described by Soko loff et al. (1977) for normal albino rats. Statistical com parison between animals receiving vehicle and those re ceiving nimodipine was made using Student's t test for ungrouped data. A detailed description of the analytical procedure for examination of the relationship between LCGU and LCBF has been published previously (Mc Culloch et aI., 1982) .
Preparation of nimodipine and experimental design
As nimodipine is sensitive to degradation by light of normal wavelengths, it was dispensed under sodium light, and the drugs, catheters, and syringes for infusion were always covered in silver foil. The drug was dissolved in a lutrol-glycerin-water mixture, and was heated gently with continuous stirring until fully dissolved. As a con trol, rats were infused with lutrol-glycerin-water vehicle, and all comparisons were made with vehicle-treated con trols.
Because of the different measurement period of the two techniques (30 s for blood flow, 45 min for glucose utili sation experiments), the initiation of the experiments was timed such that the median points of the measurements were coincident. Thus, experiments to determine LCBF were initiated 25 min after commencing the intravenous infusion of either nimodipine (1 fLg kg-I min-I) or ve hicle. LCGU measurements were initiated 15 min after commencing the infusion of nimodipine (I fLg kg -I min -I) or vehicle. Administration of the drug or solvent was con tinued until the animal was killed. With this experimental design and its attempt to ensure that the measurements of blood flow and glucose use bear as close a temporal similarity as possible, constant drug infusion has a number of attendant difficulties. For example, there is a difference of � 30% in the calculated arterial nimodipine concentrations at the initiation of the CBF measurement compared with the initiation of the measurement of glu cose use (calculated from simple pharmacokinetic anal ysis based on the plasma half-life of nimodipine of 20 min in the rat). It should be recognised, however, that al though the vasomotor effects of nimodipine in vitro are strictly dose related (Towart et aI. , 1982; Andersson et aI. , 1983) , the relationship between the concentration of nimodipine administered and the alteration in CBF in the intact animal is much more complex because of induced systemic hypotension (Haws et aI. , 1983; Mohamed et aI., 1984) . These inherent difficulties in pharmacological investigations with the autoradiographic [14C]2-DG and iodoantipyrine techniques, resulting from the different periods over which the measurements are made, are well recognised. The timing of the isotope administration in the present experimental design does provide the most representative determination of CBF for comparison with glucose utilisation averaged over a longer period.
RESULTS
General
There were no significant changes in Peo2, Po2, or pH during the administration of the drug in any of the experimental groups (Table O . The infusion of a lutrol-glycerin-water solvent in control animals did not change the MABP significantly, whereas with nimodipine (1 fLg kg-I min -I), there was a small (8%) reduction in MABP, which just failed to achieve statistical significance.
LCGU
The intravenous infusion of nimodipine (1 fLg kg-I min -I) did not alter significantly the rate of glucose utilisation in any of the 34 regions of the CNS examined. The autoradiograms from nimodi pine-treated rats were indistinguishable from those from animals that had received vehicle, although in many regions there was a tendency toward slightly lower (5 -10%) rates of glucose use during nimodi pine infusion. Even after detailed visual inspection of the autoradiograms, no region could be identified as displaying focal alterations in LCGU.
LCBF
Nimodipine (1 fLg kg-I min-I) increased LCBF significantly in 24 of the 30 grey matter regions that were investigated. Blood flow in each of the four regions of white matter was unaltered by nimodi pine infusion. The median alteration in LCBF pro voked by nimodipine administration was 32%, with the proportionately greatest increases being ob served in the posterior parietal cortex (increased by 84%), auditory cortex (64%), medial geniculate body (by 61%), and sensorimotor cortex (by 50%), and the proportionately smallest increases being ob served in the globus pallidus (by 3%) and pontine reticular formation (by 12%). Data are means ± SE, and represent the levels measured immediately prior to the measurement. There were no significant differences between the groups (unpaired Student's t test).
Relationship between LCBF and LCGU
In vehicle-treated control rats, there is an excel lent correlation (p < 0.01) between the local levels of blood flow and glucose utilisation (Fig. 2) when the data are treated overall, with the highest levels of each variable being noted in cerebral cortex, thal amus, and hippocampal formation, and the lowest values in the hypothalamus, amygdala, and white matter ( Table 2) During nimodipine infusion, an excellent corre lation (p < 0.01 ) could be demonstrated between the local levels of blood flow and glucose use (Figs. 1 and 2). The overall relationship between blood flow and glucose use during nimodipine infusion was markedly different (p = 0.0002) from that ob served in vehicle-treated animals. The disturbance of the relationship by nimodipine could be easily seen from the median value of the LCBF-to-LCGU ratio (2.5 ml fLmol-I). Although during treatment with nimodipine the local levels of blood flow and glucose use generally displayed the same regional hierarchies, interregional differences that just achieved statistical significance (p < 0.05) with the test of Greenhouse and Geisser (McCulloch et aI. , 1982) could be demonstrated in the local ratio of LCBF to LCGU. These were restricted to two re gions of grey matter, namely, sensorimotor cortex (LCBF-to-LCGU ratio 3.69 ml fLmol-l, signifi cantly greater than that in other areas with the same treatment) and globus pallidus (1 . 75 ml fLmol-l, sig nificantly lower than in other areas with the same treatment). Notwithstanding this evidence for slight regional heterogeneity in the LCBF-LCGU rela tionship with nimodipine treatment, it should be emphasised that flow and glucose use remained generally strongly correlated.
DISCUSSION
In normal brain, there is a close association, glob ally and locally, between the level of CBF and the level of energy generation that is almost exclusively the oxidative catabolism of glucose (Edvinsson and MacKenzie, 1977; Kuschinsky and Wahl, 1978; Siesj6, 1978; Kuschinsky, 1982/1 983) . In cerebro vascular pharmacology, effects on cerebral tissue metabolic activity are often the primary mechanism underlying the alterations in CBF that result from the administration of neurotransmitters or drugs. These secondary alterations in CBF in response to changes in metabolic demand may be more impor tant in determining the cerebral circulatory re sponse to various agents than are the direct vaso motor effects of the agents themselves on cerebral vessels (Edvinsson and MacKenzie, 1977; Siesj6, 4 . ... (1982) . There is an excellent correlation between local blood flow and glucose use in both the vehicle-and nimodipine-treated groups. The relationship between flow and glucose use is significantly different (p = 0.0002) in the nimodipine-treated group compared with the control group. 1978). Hitherto, although the direct actions of cal cium antagonists such as nimodipine on the cerebral vasculature have been investigated comprehen sively (Allen and Bahr, 1979; Allen and Banghart, 1979; Edvinsson et aI., 1979; To wart and Kazda, 1980, 1982; McCalden and Bevan, 1982; White et aI., 1982; Andersson et aI., 1983; Auer et aI., 1983; Brandt et aI., 1983) , there have been no systematic investigations of the effects of nimodipine or other calcium antagonists on cerebral oxygen or glucose utilisation.
There are two lines of evidence that indicate that calcium antagonists may have actions on cerebral tissue distinct from their effects on cerebral vessels. First, several workers have demonstrated the pres ence of high-affinity binding sites for nimodipine and other dihydropyridine calcium antagonists in the CNS as well as other tissues (cardiac, skeletal, J Cereh Blood Flow Metabol, Vol. 5, No. 1. 1985 and smooth muscle), and there is good evidence to believe that these highly specific binding sites, at least in peripheral tissue, represent the locus of ac tion of calcium antagonists Glossmann et aI., 1982; Bellemann et aI., 1983; Fairhurst et aI., 1983; Glossmann and Ferry, 1983; Holck et aI., 1983; Quirion, 1983) . Second, the administration of calcium antagonists can effect overt, though subtle, alterations in behaviour (Hoff meister et aI., 1982) , and changes in cerebral func tion are generally manifested as local alterations in cerebral metabolic activity (Sokoloff, 1981 (Sokoloff, , 1982 McCulloch, 1982) . However, nimodipine at an in fusion concentration with marked cerebrovascular effects did not alter the rate of glucose utilisation in any CNS region. In view of the proven utility of [14C]2-DG in mapping functional events in the CNS as they are reflected as local rates of glucose utili- It should be emphasised that this form of data analysis is not appropriate for rigorous statistical analysis, but does provide an easily assimilated graphic display [see McCulloch et al. (1982) for details of statistical analysis].
sation (McCulloch, 1982; Sokoloff, 1982) , there is little to suggest that nimodipine has other than min imal effects on functional activity in cerebral tissue, at least under the conditions of the present study. In contrast, under the same conditions, nimodipine effected marked increases in CBF in most CNS areas, and the magnitude of the local flow changes that we observed is in general accord with those observed with previous, more global measurements (Harper et aI., 1981; Kazda et aI., 1982; Haws et aI., 1983) . Investigation of regional blood flow with microsphere-trapping techniques (Haws et aI., 1983 )-rather than the truly local blood flow as sessment provided by autoradiography-revealed a broadly similar regional pattern of response to ni modipine, the only point of controversy being the marked increases in white matter blood flow with nimodipine observed in the microsphere-based study (Haws et al., 1983) , but no change in any region of white matter in the present autoradio graphically based study.
There is increasing use of the approach of em ploying complementary autoradiographic tech niques for assessing LCBF and LCaU either in par-aIlel, in two separate groups of animals, or in the same animals, using double-labelled autoradiog raphy (Kuschinsky et aI., 1981 (Kuschinsky et aI., , 1982 (Kuschinsky et aI., , 1983 Mies et aI., 1981 ; McCulloch et aI., 1982; Pulsinelli et al., 1982; Kelly and McCulloch, 1983; Ingvar and Siesjo, 1983) . The advantages that result from this approach are the spatial resolution of the measure ment, the ability to avoid distorting anaesthetic ef fects by performing the experiments in conscious animals, and having crucial, complementary data on flow and glucose use at the same location under the same experimental conditions. This last feature, with rigorous statistical evaluation (see McCulloch et aI., 1982) and judicious interpretation, can pro vide insight into the mechanism via which the al terations in CBF are achieved.
Under normal conditions, an excellent correla tion exists between the local levels of CBF and the local rates of glucose utilisation in all regions throughout the CNS (Sokoloff, 1981) . In pharma cological and pathological states, the relationship between blood flow and glucose use displays two broad categories of response. In the first type of response, the excellent correlation between local blood flow and glucose use is maintained and the ratio of blood flow to glucose use remains unaltered in all areas. [Alternatively, this can be demonstrated as no change in the intercept, IX, of the log-log glu cose use-CBF plots (Fig. 1) , or as no change in the slope derived from linear regression analysis of glu cose use-CBF (Fig. 2) .] Under these conditions of an unaltered flow-metabolism coupling, observed changes in CBF are attributable solely to concom itant alterations in underlying activity, implicating cerebral tissue and not cerebrovascular smooth muscle as the primary site of drug action. The type of response where the flow-glucose use relation ship is undisturbed has been observed previously with barbiturates (Sokoloff, 1981) , the dopamine re ceptor agonist apomorphine (McCulloch et aI., 1982) , and the ),-aminobutyric acid receptor agonist muscimol (Kelly and McCulloch, 1983) . In the second pattern of response, either the relationship between flow and glucose use is significantly dis turbed highly focally in a restricted number of re gions in pathological conditions, such as in the vi cinity of brain tumours (Blasberg et aI., 1981; Mies et aI., 1981) , in cerebral ischaemia (Pulsinelli et al., 1982) , or following administration of convulsants (Celik et aI., 1982; Ingvar and Siesjo, 1983) , or the disturbance of the flow-glucose use relationship is widespread throughout the CNS. In these cases, there is often an excellent correlation between flow and glucose use, but a marked, consistent alteration in almost every region in the magnitude of the ratio of blood flow to glucose use. This type of response has been noted previously with indomethacin, where the ratio of flow to glucose use is reduced throughout the brain (Pickard, 1981 ) , with chronic metabolic acidosis, with noradrenaline-induced hy pertension, and with ,),-hydroxybutyrate administra tion, where the flow-to-glucose use ratio throughout the brain is increased (Kuschinsky et aI., 1981 (Kuschinsky et aI., , 1982 (Kuschinsky et aI., , 1983 . The changes in the flow-glucose use relationship that result from nimodipine administra tion are of this latter type, and the rather homoge neous alteration of this relationship throughout the CNS implicates a nimodipine-sensitive process (al most certainly calcium influx into cerebrovascular smooth muscle) (Bolton, 1979; To wart and Kazda, 1980) as an integral component of the normal mech anisms via which blood flow is adjusted in vivo. The observation that the increases in CBF produced by nimodipine are not associated with any potentially damaging increases in cerebral metabolism may be an important element in the use of drugs such as nimodipine in the treatment of cerebrovascular dis ease. 
